Amy Sullivan

Amy Sullivan is a seasoned financial and corporate communications professional with extensive experience in leadership roles across various biotech and pharmaceutical companies. Currently serving as Chief Financial Officer at IO Biotech since October 2022, Amy has previously held CFO positions at TABA B.V. and Kiadis Pharma. Additional roles include Chief Strategy Officer at Kiadis Pharma, Senior Vice President of Corporate Affairs at Keryx Biopharmaceuticals, and Vice President of Investor Relations and Corporate Communications at AMAG Pharmaceuticals. Early career highlights include senior positions in corporate communications and investor relations at Idenix, Euro RSCG Life/NRP, and Genencor International. Amy holds an MBA in Business/Corporate Communications from Bentley University.